• Masimo (Irvine, California) reported that a new clinical study, recently published in the Journal of Emergency Medicine, found the Masimo Rainbow SET Rad-57 Pulse CO-Oximeter to be “a safe, easily applied tool at triage that can identify cases of unsuspected elevated levels of carbon monoxide (CO) poisoning” otherwise undetected. The research team noted that identification of CO toxicity in the ED is challenging because many patients may not know or suspect that they were exposed to CO and are unable to provide clinicians with sufficient history to prompt testing for carboxyhemoglobin (COHb). In addition, the symptoms of CO poisoning can be similar to the flu. However, missing the opportunity to diagnose CO poisoning at the ED because screening large populations of patients by invasive blood testing for CO toxicity is not practical and not routinely performed in the ED setting can lead to “inadvertently returning a patient to the site of CO exposure and may lead to further toxicity with the possibility of long-term neurological, psychiatric, or cardiovascular complications.” Masimo is the inventor of Pulse CO-Oximetry and Measure-Through-Motion & Low Perfusion Pulse Oximetry.

• Siemens Healthcare (Malvern, Pennsylvania) has received FDA clearance for two solutions for urological applications: Lithoskop and Modularis Variostar. Encompassing lithotripsy, endourology, urodiagnostics, and percutaneous interventions, Lithoskop is a multifunctional, high-end system for many urological applications. Its flexible shockwave head makes patient repositioning a thing of the past. The system offers stone localization with X-ray, as well as inline X-ray and inline ultrasound imaging. Lithoskop’s high-performance X-ray generator and powerful image intensifier with 1 K2 matrix delivers reliable image quality for optimal diagnosis and therapy. Modularis Variostar provides a urology platform that consists of components that can be used separately or in combination. It is suited for traditional urodiagnostics, extra- and intracorporeal shockwave therapy (ESWL, ISWL), and endourological interventions.